Cibus, Inc. (CBUS)
NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
As of 03:06PM EDT. Market open.
| Previous Close | 16.74 |
| Open | 17.37 |
| Bid | 17.05 x 100 |
| Ask | 17.43 x 100 |
| Day's Range | 17.06 - 17.52 |
| 52 Week Range | 8.90 - 38.85 |
| Volume | |
| Avg. Volume | 66,612 |
| Market Cap | 422.496M |
| Beta (5Y Monthly) | 1.95 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -25.95 |
| Earnings Date | May 09, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 23.00 |
Simply Wall St.Cibus, Inc.'s (NASDAQ:CBUS) top owners are individual investors with 53% stake, while 26% is held by institutions
Key Insights Cibus' significant individual investors ownership suggests that the key decisions are influenced by...
GlobeNewswireCibus to Report First Quarter 2024 Financial Results on May 9, 2024 and Host Conference Call
SAN DIEGO, April 25, 2024 (GLOBE NEWSWIRE) -- Cibus, Inc. (Nasdaq: CBUS), a leading agricultural biotechnology company that uses proprietary gene editing technologies to develop plant traits (or specific genetic characteristics) in seeds, today announced that the company will report first quarter 2024 financial results on Thursday, May 9, 2024. Cibus’ management team will host a conference call and audio webcast at 4:30 p.m. ET on that day to discuss the financial results and other company updat
Simply Wall St.Cibus Full Year 2023 Earnings: Revenues Beat Expectations, EPS Lags
Cibus ( NASDAQ:CBUS ) Full Year 2023 Results Key Financial Results Net loss: US$267.6m (loss widened by US$250.7m from...
© 2024 Yahoo. All rights reserved.